Accurate Conformation-Dependent Molecular Electrostatic Potentials for High-Throughput In Silico Drug Discovery

被引:98
|
作者
Puranen, J. Santeri [1 ]
Vainio, Mikko J. [1 ]
Johnson, Mark S. [1 ]
机构
[1] Abo Akad Univ, Struct Bioinformat Lab, Dept Biochem & Pharm, FI-20520 Turku, Finland
基金
芬兰科学院;
关键词
partial charges; molecular electrostatic potential; conformation dependent; polarizable; electronegativity equalization; ELECTRONEGATIVITY EQUALIZATION METHOD; DERIVING ATOMIC CHARGES; EFFICIENT GENERATION; AM1-BCC MODEL; HARDNESS; PARAMETERIZATION; VALIDATION; ALGORITHM; DENSITY; SMILES;
D O I
10.1002/jcc.21460
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The atom-centered partial charges-approximation is commonly used in current molecular modeling tools as a computationally inexpensive alternative to quantum mechanics for modeling electrostatics. Even today, the use of partial charges remains useful despite significant advances in improving the efficiency of oh initio methods. Here, we report on new parameters for the EEM and SEKEEM electronegativity equalization-based methods for rapidly determining partial charges that will accurately model the electrostatic potential of flexible molecules. The developed parameters cover most pharmaceutically relevant chemistries, and charges obtained using these parameters reproduce the B3LYP/cc-pVTZ reference electrostatic potential of a set of FDA-approved drug molecules at best to an average accuracy of 13 +/- 4 kJ mol(-1); thus, equipped with these parameters electronegativity equalization-based methods rival the current best non-quantum mechanical methods, such as AM1-BCC, in accuracy, yet incur a lower computational cost. Software implementations of EEM and SEKEEM, including the developed parameters, are included in the conformer-generation tool BALLOON, available free of charge at http://web.abo.fi/fak/mnf/bkf/research/johnson/software.php. (C) 2009 Wiley Periodicals, Inc. J Comput Chem 31: 1722-1732, 2010
引用
收藏
页码:1722 / 1732
页数:11
相关论文
共 50 条
  • [31] High-throughput crystallography for lead discovery in drug design
    Blundell, TL
    Jhoti, H
    Abell, C
    NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (01) : 45 - 54
  • [32] High-throughput crystallography for lead discovery in drug design
    Tom L. Blundell
    Harren Jhoti
    Chris Abell
    Nature Reviews Drug Discovery, 2002, 1 : 45 - 54
  • [33] High-throughput crystallization and structure determination in drug discovery
    Stewart, L
    Clark, R
    Behnke, C
    DRUG DISCOVERY TODAY, 2002, 7 (03) : 187 - 196
  • [34] High-throughput virtual screening for drug discovery in parallel
    Toledo-Sherman, LM
    Chen, DQ
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2002, 5 (03) : 414 - 421
  • [35] High-Throughput Purification Platform in Support of Drug Discovery
    Liu, Min
    Chen, Kuanchang
    Christian, Denny
    Fatima, Tazeen
    Pissamitski, Natalya
    Streckfuss, Eric
    Zhang, Chaowei
    Xia, Lei
    Borges, Scott
    Shi, Zhicai
    Vachal, Petr
    Tata, James
    Athanasopoulos, John
    ACS COMBINATORIAL SCIENCE, 2012, 14 (01) : 51 - 59
  • [36] C. elegans in high-throughput drug discovery
    O'Reilly, Linda P.
    Luke, Cliff J.
    Perlmutter, David H.
    Silverman, Gary A.
    Pak, Stephen C.
    ADVANCED DRUG DELIVERY REVIEWS, 2014, 69 : 247 - 253
  • [37] High-throughput kinase profiling as a platform for drug discovery
    Goldstein, David M.
    Gray, Nathanael S.
    Zarrinkar, Patrick P.
    NATURE REVIEWS DRUG DISCOVERY, 2008, 7 (05) : 391 - 397
  • [38] Advances in high-throughput mass spectrometry in drug discovery
    Duenas, Maria Emilia
    Peltier-Heap, Rachel E.
    Leveridge, Melanie
    Annan, Roland S.
    Buttner, Frank H.
    Trost, Matthias
    EMBO MOLECULAR MEDICINE, 2023, 15 (01)
  • [39] Hypothesis Testing in High-Throughput Screening for Drug Discovery
    Prummer, Michael
    JOURNAL OF BIOMOLECULAR SCREENING, 2012, 17 (04) : 519 - 529
  • [40] High-throughput conformation-sensitive gel electrophoresis for discovery of SNPs
    Leung, YF
    Tam, POS
    Tong, WC
    Baum, L
    Choy, KW
    Lam, DSC
    Pang, CP
    BIOTECHNIQUES, 2001, 30 (02) : 334 - +